Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
Stanford Children's Hospital
mi
from
Palo Alto, CA
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
Stanford Children's Hospital
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
Stanford University
mi
from
Stanford, CA
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
Children's Hospital Colorado
mi
from
Aurora, CO
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
Children's National Health System
mi
from
Washington,
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
Children's National Health System
mi
from
Washington,
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
Children's Healthcare of Atlanta, Aflac Cancer and Blood Center
mi
from
Atlanta, GA
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
Children's Healthcare of Atlanta, Aflac Cancer and Blood Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
University of Chicago
mi
from
Chicago, IL
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
Children's Hospital
mi
from
New Orleans, LA
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
Children's Hospital
mi
from
New Orleans, LA
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
Johns Hopkins University
mi
from
Baltimore, MD
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
Brigham and Woman's Hospital
mi
from
Boston, MA
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
Brigham and Woman's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
Univ of Minnesota
mi
from
Minneapolis, MN
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
Children's Mercy Hospital
mi
from
Kansas City, MO
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
Washington University School of Medicine
mi
from
Saint Louis, MO
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
University of Nebraska
mi
from
Omaha, NE
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
University of Nebraska
mi
from
Omaha, NE
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
Montifore Medical Center
mi
from
Bronx, NY
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
Montifore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
Weill Cornell Medical College/New York Presbyterian Hospital
mi
from
New York, NY
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
Weill Cornell Medical College/New York Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
Levine Children's Hospital
mi
from
Charlotte, NC
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
Levine Children's Hospital
mi
from
Charlotte, NC
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
Cincinnatti Children's Hospital
mi
from
Cincinnatti, OH
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
Cincinnatti Children's Hospital
mi
from
Cincinnatti, OH
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
St. Jude Children's Hospital
mi
from
Memphis, TN
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
St. Jude Children's Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
Cook Children's Medical Center
mi
from
Fort Worth, TX
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
Cook Children's Medical Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
Baylor College of Medicine
mi
from
Houston, TX
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
Intermountain Healthcare Research
mi
from
Salt Lake City, UT
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
Intermountain Healthcare Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
University of Utah, Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
University of Utah, Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
Fred Hutchingson Cancer Center
mi
from
Seattle, WA
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
Fred Hutchingson Cancer Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
Seattle Children's Hospital
mi
from
Seattle, WA
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
Medical College of Wisconsin
mi
from
Milwaukee, WI
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated:  8/7/2015
M.D. Anderson Cancer Center
mi
from
Houston, TX
Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)
Status: Enrolling
Updated: 8/7/2015
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
The Role of Dietary Fat on Postprandial Endotoxemia in Healthy Adults
Dietary Fat Affects Postprandial Serum Endotoxin Concentration in Healthy Adults
Status: Enrolling
Updated:  8/10/2015
Nutrition and Wellness Research Center
mi
from
Ames, IA
The Role of Dietary Fat on Postprandial Endotoxemia in Healthy Adults
Dietary Fat Affects Postprandial Serum Endotoxin Concentration in Healthy Adults
Status: Enrolling
Updated: 8/10/2015
Nutrition and Wellness Research Center
mi
from
Ames, IA
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Alabama Therapeutics CRS
mi
from
Birmingham, AL
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Alabama Therapeutics CRS
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Usc La Nichd Crs
mi
from
Alhambra, CA
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Usc La Nichd Crs
mi
from
Alhambra, CA
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
University of California, UC San Diego CRS
mi
from
La Jolla, CA
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
University of California, UC San Diego CRS
mi
from
La Jolla, CA
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Miller Children's Hosp. Long Beach CA NICHD CRS
mi
from
Long Beach, CA
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Miller Children's Hosp. Long Beach CA NICHD CRS
mi
from
Long Beach, CA
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
University of Southern California CRS
mi
from
Los Angeles, CA
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
University of Southern California CRS
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
UCLA CARE Center CRS
mi
from
Los Angeles, CA
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
UCLA CARE Center CRS
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Stanford AIDS Clinical Trials Unit CRS
mi
from
Palo Alto, CA
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Stanford AIDS Clinical Trials Unit CRS
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
UCSD Antiviral Research Center CRS
mi
from
San Diego, CA
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
UCSD Antiviral Research Center CRS
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Ucsf Hiv/Aids Crs
mi
from
San Francisco, CA
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Ucsf Hiv/Aids Crs
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
University of Colorado Hospital CRS
mi
from
Aurora, CO
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
University of Colorado Hospital CRS
mi
from
Aurora, CO
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Denver Public Health CRS
mi
from
Denver, CO
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Denver Public Health CRS
mi
from
Denver, CO
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Georgetown University CRS (GU CRS)
mi
from
Washington,
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Georgetown University CRS (GU CRS)
mi
from
Washington,
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Howard Univ. Washington DC NICHD CRS
mi
from
Washington,
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Howard Univ. Washington DC NICHD CRS
mi
from
Washington,
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
South Florida CDTC Ft Lauderdale NICHD CRS
mi
from
Fort Lauderdale, FL
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
South Florida CDTC Ft Lauderdale NICHD CRS
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Univ. of Florida Jacksonville NICHD CRS
mi
from
Jacksonville, FL
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Univ. of Florida Jacksonville NICHD CRS
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Pediatric Perinatal HIV Clinical Trials Unit CRS
mi
from
Miami, FL
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Pediatric Perinatal HIV Clinical Trials Unit CRS
mi
from
Miami, FL
Click here to add this to my saved trials